Skip to content
10-K

Annual Report

Cellcyte Genetics Corp.

0001056520-14-000056

← back to feed
Filed
Apr 15, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Apr 14, 2014 82.33M sh
Shares Diluted FY 2013 · Dec 31, 2013 82.33M sh
Shares Diluted FY 2013 · Dec 31, 2012 88.79M sh
Operating Cash Flow FY 2013 · Dec 31, 2013 −$62.66K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$5.39M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$78.37K
Stockholders Equity FY 2013 · Dec 31, 2013 −$819.8K
Stockholders Equity FY 2013 · Dec 31, 2012 −$655.76K
Current Liabilities FY 2013 · Dec 31, 2013 $351.34K
Current Liabilities FY 2013 · Dec 31, 2012 $334.97K
Current Assets FY 2013 · Dec 31, 2013 $9.03K
Current Assets FY 2013 · Dec 31, 2012 $9.4K
Total Assets FY 2013 · Dec 31, 2013 $9.03K
Total Assets FY 2013 · Dec 31, 2012 $25.62K
Eps Diluted FY 2013 · Dec 31, 2013 $0.00
Eps Diluted FY 2013 · Dec 31, 2012 $0.01
Eps Basic FY 2013 · Dec 31, 2013 $0.00
Eps Basic FY 2013 · Dec 31, 2012 $0.01
Sga Expense FY 2013 · Dec 31, 2013 $62.45K
Sga Expense FY 2013 · Dec 31, 2013 $2.66M
Sga Expense FY 2013 · Dec 31, 2012 $74.78K
Rd Expense FY 2013 · Dec 31, 2013 $1.3M
Net Income FY 2013 · Dec 31, 2013 −$164.04K
Net Income FY 2013 · Dec 31, 2013 −$12.69M
Net Income FY 2013 · Dec 31, 2012 $585.83K